Aortic source of brain embolism

  • Geoffrey A. Donnan
  • Stephen M. Davis
  • Elizabeth F. Jones
  • Pierre Amarenco
Article

Opinion statement

Aortic arch atheroma has more recently been identified as an independent risk factor for ischemic stroke. Initially, this was a result of careful autopsy observations, then followed by a series of in vivo studies in which aortic arch atheroma was identified by transesophageal echocardiography. The association of aortic arch atheroma with ischemic stroke is most likely causal, given that the stroke risk increases with increasing thickness of arch atheroma. There is quite a sharp increase in stroke risk for atheroma of 4 mm or greater compared with lesser thicknesses. The clinical diagnosis is suggested when transient ischemic attack or ischemic stroke has occurred in which no obvious cardiac or arterial source of embolism is found. The presence of aortic arch atheroma is usually detected by transesophageal echocardiography and sometimes by magnetic resonance imaging or computed tomography. There is uncertainty about clinical management, particularly for secondary prevention. Options include the use of antiplatelet agents, anticoagulants, thrombolysis, or surgery. The latter two options have only been described rarely in case reports. Of the less invasive approaches, combination antiplatelet therapy with aspirin and clopidogrel is favored, or the use of warfarin. The Aortic arch Related Cerebral Hazard (ARCH) trial is being conducted to determine which of these is more effective in minimizing a composite outcome cluster of ischemic stroke, intracranial hemorrhage, myocardial infarction, peripheral embolism, or vascular death. Other more general management strategies should include reasonably aggressive risk factor control with blood pressure and lipid-lowering therapies and, if indicated, careful diabetic control.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349:1436–1442.PubMedCrossRefGoogle Scholar
  2. 2.
    Donnan G: The mechanisms of stroke. Dialogues Cardiovasc Med 2003, in press.Google Scholar
  3. 3.
    Stone DA, Hawke MW, LaMonte M, et al.: Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J 1995, 130:105–108.PubMedCrossRefGoogle Scholar
  4. 4.
    Amarenco P, Duyckaerts C, Tzourio C, et al.: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992, 326:221–225.PubMedCrossRefGoogle Scholar
  5. 5.
    Amarenco P, Cohen A, Tzourio C, et al.: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474–1479.PubMedCrossRefGoogle Scholar
  6. 6.
    Jones EF, Kalman JM, Calafiore P, et al.: Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995, 26:218–224.PubMedGoogle Scholar
  7. 7.
    Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group [no authors listed]. N Engl J Med 1996, 334:1216–1221.Google Scholar
  8. 8.
    Cohen A, Tzourio C, Bertrand B, et al.: Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997, 96:3838–3841.PubMedGoogle Scholar
  9. 9.
    Barnett HJ, Haines SJ: Carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993, 328:276–279.PubMedCrossRefGoogle Scholar
  10. 10.
    Agmon Y, Khandheria BK, Meissner I, et al.: Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol 2002, 89:262–267.PubMedCrossRefGoogle Scholar
  11. 11.
    Beaglehole R, Bonita R, Kjellstrom T: In Basic Epidemiology. Geneva: World Health Organization; 1993.Google Scholar
  12. 12.
    Kazui S, Levi CR, Jones EF, et al.: Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology 2000, 54:1385–387. An association between aortic arch atheroma and lacunar infarction were shown to be an index of atheromatous load.PubMedGoogle Scholar
  13. 13.
    Krinsky GA, Rofsky NM, DeCorato DR, et al.: Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997, 202:183–193.PubMedGoogle Scholar
  14. 14.
    Daniel WG, Erbel R, Kasper W, et al.: Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991, 83:817–821.PubMedGoogle Scholar
  15. 15.
    Kutz SM, Lee VS, Tunick PA, et al.: Atheromas of the thoracic aorta: a comparison of transesophageal echocardiography and breath-hold gadolinium-enhanced 3-dimensional magnetic resonance angiography. J Am Soc Echocardiogr 1999, 12:853–858. Demonstration of the magnetic resonance technique for imaging aortic arch.PubMedCrossRefGoogle Scholar
  16. 16.
    Tenenbaum A, Garniek A, Shemesh J, et al.: Dualhelical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography. Radiology 1998, 208:153–158.PubMedGoogle Scholar
  17. 17.
    Khatibzadeh M, Mitusch R, Stierle U, et al.: Aorticatherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996, 27:664–669.PubMedCrossRefGoogle Scholar
  18. 18.
    Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM: Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993, 71:1208–1212.PubMedCrossRefGoogle Scholar
  19. 19.
    Di Tullio MR, Sacco RL, Gersony D, et al.: Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996, 46:1560–1566.PubMedGoogle Scholar
  20. 20.
    Davila-Roman VG, Barzilai B, Wareing TH, et al.: Atherosclerosis of the ascending aorta. Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke 1994, 25:2010–2016.PubMedGoogle Scholar
  21. 21.
    Laperche T, Laurian C, Roudaut R, Steg PG: Mobile thromboses of the aortic arch without aortic debris. A transesophageal echocardiographic finding associated with unexplained arterial embolism. The Filiale Echocardiographie de la Societe Francaise de Cardiologie. Circulation 1997, 96:288–294.PubMedGoogle Scholar
  22. 22.
    Dee W, Geibel A, Kasper W, et al.: Mobile thrombi in atherosclerotic lesions of the thoracic aorta: the diagnostic impact of transesophageal echocardiography. Am Heart J 1993, 126(3 Pt 1):707–710.PubMedCrossRefGoogle Scholar
  23. 23.
    Dressler FA, Craig WR, Castello R, Labovitz AJ: Mobile aortic atheroma and systemic emboli: efficacy of anti-coagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998, 31:134–138.PubMedCrossRefGoogle Scholar
  24. 24.
    Montgomery DH, Ververis JJ, McGorisk G, et al.: Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 1996, 27:95–101.PubMedCrossRefGoogle Scholar
  25. 25.
    Hall P, Nakamura S, Maiello L, et al.: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996, 93:215–222.PubMedGoogle Scholar
  26. 26.
    Schomig A, Neumann FJ, Kastrati A, et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996, 334:1084–1089.PubMedCrossRefGoogle Scholar
  27. 27.
    Goods CM, al-Shaibi KF, Liu MW, et al.: Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. Am J Cardiol 1996, 78:1042–1044.PubMedCrossRefGoogle Scholar
  28. 28.
    Topol EJ, Serruys PW: Frontiers in interventional cardiology. Circulation 1998, 98:1802–1820.PubMedGoogle Scholar
  29. 29.
    Bertrand ME, Rupprecht HJ, Urban P, et al.: Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000, 102:624–629.PubMedGoogle Scholar
  30. 30.
    A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAP-RIE). CAPRIE Steering Committee [no authors listed]. Lancet 1996, 348:1329–1339.Google Scholar
  31. 31.
    Harker LA, Marzec UM, Kelly AB, et al.: Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998, 98:2461–2469.PubMedGoogle Scholar
  32. 32.
    Yusuf S, Zhao F, Mehta SR, et al.: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494–502.PubMedCrossRefGoogle Scholar
  33. 33.
    Vaduganathan P, Ewton A, Nagueh SF, et al.: Pathologic correlates of aortic plaques, thrombi and mobile “aortic debris” imaged in vivo with transesophageal echocardiography. J Am Coll Cardiol 1997, 30:357–363.PubMedCrossRefGoogle Scholar
  34. 34.
    Blackshear JL, Jahangir A, Oldenburg WA, Safford RE: Digital embolization from plaque-related thrombus in the thoracic aorta: identification with transesophageal echocardiography and resolution with warfarin therapy. Mayo Clin Proc 1993, 68:268–272.PubMedGoogle Scholar
  35. 35.
    Blackshear JL, Zabalgoitia M, Pennock G, et al.: Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. SPAF TEE Investigators. Stroke Prevention and Atrial Fibrillation. Transesophageal echocardiography. Am J Cardiol 1999, 83:453–455, A9.PubMedCrossRefGoogle Scholar
  36. 36.
    Petty GW, Brown RD Jr, Whisnant JP, et al.: Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med 1999, 130:14–22.PubMedGoogle Scholar
  37. 37.
    Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators [no authors listed]. Arch Intern Med 1996, 156:409–416.Google Scholar
  38. 38.
    Mehta SR, Yusuf S: The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J 2000, 21:2033–2041.PubMedCrossRefGoogle Scholar
  39. 39.
    Hausmann D, Gulba D, Bargheer K, et al.: Successful thrombolysis of an aortic arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992, 327:500–501.PubMedCrossRefGoogle Scholar
  40. 40.
    Ito H, Takahash IK, Sasaki H, et al.: Large thrombus in the ascending aorta successfully treated by thrombolysisan unusual cause of acute massive myocardial infarction. Jpn Circ J 2001, 65:572–574.PubMedCrossRefGoogle Scholar
  41. 41.
    Lancaster G, Lovoulos CJ, Moussouttas M, et al.: Aortic arch replacement for recurrent cerebral embolization. Ann Thorac Surg 2002, 73:291–294. Good example of surgical techniques used to replace aortic arch.PubMedCrossRefGoogle Scholar
  42. 42.
    Belden JR, Caplan LR, Bojar RM, et al.: Treatment of multiple cerebral emboli from an ulcerated, thrombogenic ascending aorta with aortectomy and graft replacement. Neurology 1997, 49:621–622.PubMedGoogle Scholar
  43. 43.
    Rokkas CK, Kouchoukos NT: Surgical management of the severely atherosclerotic ascending aorta during cardiac operations. Semin Thorac Cardiovasc Surg 1998, 10:240–246.PubMedGoogle Scholar
  44. 44.
    Baribeau YR, Westbrook BM, Charlesworth DC, Maloney CT: Arterial inflow via an axillary artery graft for the severely atheromatous aorta. Ann Thorac Surg 1998, 66:33–37.PubMedCrossRefGoogle Scholar
  45. 45.
    Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack [no authors listed]. Lancet 2001, 358:1033–1041.Google Scholar
  46. 46.
    MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial [no authors listed]. Lancet 2002, 360:7–22.Google Scholar
  47. 47.
    Sen S, Oppenheimer SM, Lima J, Cohen B: Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients. Stroke 2002, 33:930–935.PubMedCrossRefGoogle Scholar
  48. 48.
    The VITATOPS (Vitamins To Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke [no authors listed]. Cerebrovasc Dis 2002, 13:120–126. Homocysteine was identified as a factor associated with progression of aortic arch atheroma.Google Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Geoffrey A. Donnan
    • 1
  • Stephen M. Davis
  • Elizabeth F. Jones
  • Pierre Amarenco
  1. 1.National Stroke Research Institute, Austin & Repatriation Medical CentreWest HeidelbergAustralia

Personalised recommendations